GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (GREY:PTKMF) » Definitions » Cash Receipts from Operating Activities

PTKMF (PT Kimia Farma Tbk) Cash Receipts from Operating Activities : $727.08 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is PT Kimia Farma Tbk Cash Receipts from Operating Activities?

PT Kimia Farma Tbk's Cash Receipts from Operating Activities for the three months ended in Jun. 2024 was $180.71 Mil.

PT Kimia Farma Tbk's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 was $727.08 Mil.


PT Kimia Farma Tbk Cash Receipts from Operating Activities Historical Data

The historical data trend for PT Kimia Farma Tbk's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Cash Receipts from Operating Activities Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Receipts from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 667.88 751.24 871.85 618.07 647.31

PT Kimia Farma Tbk Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.47 245.16 109.65 191.56 180.71

PT Kimia Farma Tbk Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $727.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kimia Farma Tbk Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Industry
Traded in Other Exchanges
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in three categories including Ethical, Generic and others. Some of its product offerings include Topgesic, Protofen, Neurodial, Omeprazole, Antalgin, Pethidine, Salicylfresh and Doveri. It generates maximum revenue from the retail segment.

PT Kimia Farma Tbk Headlines

No Headlines